Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will test the hypothesis that the drugs propranolol and metoprolol will result in greater increases in core body temperature during 3 hours of extreme heat exposure in older adults.
Older individuals are more likely to die or become ill during heat waves. During the 1995 Chicago heat wave, there was 35% increase in hospital admissions for individuals older than 65 years of age. Moreover, adults over the age of 65 have a heat-related death rate that is more than double any other age group. Therefore, with an increasing elderly population that is expected to rise by 60% (to 78 million) by 2035, the causes of this excess mortality must be understood to better protect the ageing United States population. It is notable that selective and non-selective beta blocker drugs are commonly prescribed to older individuals with cardiovascular diseases. In younger individuals exposed to a heat stress, beta blocker administration reduced whole-body sweat rate and skin blood flow responses resulting in greater increases in core body temperature. Notably, nothing is known regarding the effects of beta blockers on thermoregulatory responses during heat exposure in older individuals.
This project will evaluate core body temperature responses to selective and non-selective beta blocker drugs during simulated heat wave exposure in older individuals.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo, then Propranolol, then Metoprolol | Experimental |
| |
| Placebo, then Metoprolol, then Propranolol | Experimental |
| |
| Propranolol, then Placebo, then Metoprolol | Experimental |
| |
| Propranolol, then Metoprolol, then Placebo | Experimental |
| |
| Metoprolol, then Placebo, then Propranolol | Experimental |
| |
| Metoprolol, then Propranolol, then Placebo | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ambient Heat | Other | Subjects will spend 3-hours in a heat chamber at 41°C and 40% humidity. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Internal temperature | The change in internal temperature to the 3-hour heat exposure will be measured. | Continuously throughout the 3-hour heat exposure. |
| Whole body sweat rate | Whole body sweat rate will be measured via changes in pre/post nude body mass. | Nude body mass will be measured before and after the 3-hour heat exposure. |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate | Heart rate will be measured via electrocardiogram. | Continuously throughout the 3-hour heat exposure. |
| Arterial blood pressure | Systolic and diastolic arterial blood pressures will be measured via a brachial blood pressure cuff. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Erin Harper, MS | Contact | 214-345-4737 | erinharper@texashealth.org | |
| Courtney Kirby, RN | Contact | 214-345-6502 | courtneykirby@texashealth.org |
| Name | Affiliation | Role |
|---|---|---|
| Craig Crandall, PhD | Univ of Texas Southwestern Med Ctr | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IEEM Texas Health Presbyterian Hospital Dallas | Recruiting | Dallas | Texas | 75231 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018882 | Heat Stress Disorders |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
Not provided
Not provided
We will first collect participant demographics, medical history, anthropometrics (body mass, height and composition). Individuals will be exposed to 3 hours in a hot environmental condition after receiving the placebo, propranolol, or metoprolol.
Prior to entering the environmental chamber, baseline data will be collected while resting in a thermoneutral environment. Drug or placebo will be administered. Participants will then enter the environmental chamber and will be seated in a semi-recumbent position on a chair with breathable fabric to minimize impediments to heat dissipation. Periodically throughout the simulated heat-wave participants will lightly exercise to simulate metabolic heat production associated with activities of daily living (~3 metabolic equivalents; METS). Throughout the heat-wave simulation trials we comprehensively evaluate the thermoregulatory and cardiovascular responses.
Not provided
Not provided
Neither the participants nor the researchers will know whether the participant received the placebo or one of the beta blocking drugs. Masking will be performed by the research nurse who will know which drug the participant received.
| Continuously throughout the 3-hour heat exposure. |